NCT02429154View on ClinicalTrials.gov

Assessment of Cerebral Vasoreactivity Using Near-infrared Spectroscopy (NIRS) in Infants (VARO)

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

September 30, 2017

Conditions
Hypercapnia
Interventions
OTHER

Normocapnia

Normoventilation in order to have an end-tidal carbon dioxide (ETCO2) of 5.5 kiloPascal (kPa)

OTHER

Mild Hypercapnia

Decrease in minute ventilation in order to increase ETCO2 to 6.5 kPa

Trial Locations (1)

1206

Geneva Children's Hospital, Geneva

All Listed Sponsors
lead

Walid HABRE

OTHER

NCT02429154 - Assessment of Cerebral Vasoreactivity Using Near-infrared Spectroscopy (NIRS) in Infants (VARO) | Biotech Hunter | Biotech Hunter